Clinical Trials Browser

Interventional × gadoterate meglumine × Clear all

NCT06057168 2026-01-29

GDX-44-016

Phase 3 Completed

138 enrolled 7 charts

Brain Neoplasms

NCT04373564 2026-01-22

ODYSSEY

Phase 4 Recruiting

BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT04341129 2023-12-05

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Phase EARLY_PHASE1 Completed

Breast Diseases, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Fibroadenoma

NCT01806740 2019-08-08

DCE-MRI

Phase 4 Terminated

37 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT02034708 2016-12-30

REMIND

Phase 4 Completed

279 enrolled 9 charts

Brain Neoplasms

NCT03000036 2016-12-21

Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients

Phase NA Completed

Breast Neoplasms

NCT01657747 2015-07-02

S53580

Phase NA Completed

Ovarian Neoplasms